Literature DB >> 12792853

Nuclear factor-kappaB and its role in sepsis-associated organ failure.

Edward Abraham1.   

Abstract

Nuclear factor (NF)-kappaB is involved in regulating the transcription of many of the immunomodulatory mediators involved in the development of sepsis-induced organ failure. Kinase pathways involving p38 and Akt and initiated by engagement of Toll-like receptors modulate transcriptional activity of NF-kappaB, but apparently through different mechanisms. Increased activation of NF-kappaB occurs with sepsis, and greater levels of nuclear accumulation of NF-kappaB are associated with higher rates of mortality and worse clinical outcome. The percentage of apoptotic neutrophils is reduced in sepsis, and inhibition of nuclear translocation of NF-kappaB restores neutrophil apoptosis to baseline levels. In models of sepsis, suppression of NF-kappaB activation decreases acute inflammatory processes and organ dysfunction. Because NF-kappaB occupies a central role in signaling pathways important in sepsis, modulation of NF-kappaB activity may be an appropriate therapeutic target in patients with sepsis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12792853     DOI: 10.1086/374750

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  80 in total

1.  Role of nuclear transcription factor-kappaB in endotoxin-induced shock in rats.

Authors:  Jin Wang; Guangtian Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  Compound 9a, a novel synthetic histone deacetylase inhibitor, protects against septic injury in mice by suppressing MAPK signalling.

Authors:  So-Jin Kim; Ki Seon Baek; Hyun-Ju Park; Young Hoon Jung; Sun-Mee Lee
Journal:  Br J Pharmacol       Date:  2016-02-22       Impact factor: 8.739

Review 3.  Gene silencing in severe systemic inflammation.

Authors:  Charles E McCall; Barbara K Yoza
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

Review 4.  Controversial role of toll-like receptors in acute pancreatitis.

Authors:  Juan Vaz; Hamid Akbarshahi; Roland Andersson
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

Review 5.  Melatonin, clock genes and mitochondria in sepsis.

Authors:  Darío Acuña-Castroviejo; Ibtissem Rahim; Carlos Acuña-Fernández; Marisol Fernández-Ortiz; Jorge Solera-Marín; Ramy K A Sayed; María E Díaz-Casado; Iryna Rusanova; Luis C López; Germaine Escames
Journal:  Cell Mol Life Sci       Date:  2017-08-07       Impact factor: 9.261

Review 6.  Subcellular Energetics and Metabolism: A Cross-Species Framework.

Authors:  Robert H Thiele
Journal:  Anesth Analg       Date:  2017-06       Impact factor: 5.108

7.  Role of Shenfu Injection in rats with systemic inflammatory response syndrome.

Authors:  Jin Wang; Li-fen Qiao; Guang-tian Yang
Journal:  Chin J Integr Med       Date:  2008-06-21       Impact factor: 1.978

Review 8.  Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.

Authors:  Derek S Wheeler; Basilia Zingarelli; William J Wheeler; Hector R Wong
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2009-06

9.  Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.

Authors:  Rajesh K Thimmulappa; Ralph J Fuchs; Deepti Malhotra; Catherine Scollick; Kassim Traore; Jay H Bream; Michael A Trush; Karen T Liby; Michael B Sporn; Thomas W Kensler; Shyam Biswal
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

10.  Alpha-lipoic acid exerts anti-inflammatory effects on lipopolysaccharide-stimulated rat mesangial cells via inhibition of nuclear factor kappa B (NF-κB) signaling pathway.

Authors:  Guofu Li; Jiahong Fu; Yang Zhao; Kaiqiang Ji; Ting Luan; Bin Zang
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.